Cytokinesis requires the constriction of ESCRT--III filaments on the side of the midbody, where abscission occurs. After ESCRT recruitment at the midbody, it is not known how the ESCRT--III machinery localizes to the abscission site. To reveal novel actors involved in abscission, we obtained the proteome of intact, post--abscission midbodies (Flemmingsome) and identified 489 proteins enriched in this organelle. Among those proteins, we further characterized a plasma membrane--to--ESCRT module composed of the transmembrane proteoglycan syndecan--4, ALIX and syntenin, a protein that bridges ESCRT--III/ALIX to syndecans. The three proteins were highly recruited first at the midbody then at the abscission site, and their depletion delayed abscission.
prior to abscission, the ESCRT--III machinery is progressively enriched to the future abscission site on the midbody side 12, 13, 20, 21, 25, 30, 31, 36, 38, 39 .
Since MKLP1 and CEP55 are only present at the midbody 38 Here, we first set up a novel method, using FACS, for purifying intact post--cytokinetic MBRs, and identified by proteomics 489 proteins enriched in this organelle. Among them, we focused on the transmembrane protein syndecan--4 and associated proteins syntenin--1 (hereafter "syntenin") and ALIX, all highly enriched. Indeed, ALIX directly interacts with ESCRT--III 40 and we previously showed that syntenin can bind directly and simultaneously to the cytoplasmic tail of syndecans in vitro 41, 42 . We thus hypothesized that ALIX--syntenin could mechanistically bridge the ESCRT machinery to the plasma membrane through the transmembrane proteoglycan syndecan--4. Interestingly, overexpression of syndecan--4 mutants that cannot be properly phosphorylated on the cytoplasmic tail was reported to perturb cytokinesis 43 . However, the underlying mechanism is unknown and whether syndecan--4 is actually required for cytokinesis has not been addressed. We here reveal that, together with ALIX, both syndecan--4 and syntenin are required for successful abscission, as they enable the stable recruitment of the ESCRT--III machinery specifically at the abscission site.
RESULTS

The Flemmingsome, or proteome of MBRs, reveals new candidates for abscission
The proteome of intercellular bridges from CHO cells previously proved to be a particularly successful approach to identify new proteins required for cytokinesis 44 .
However, the use of detergents during the purification steps precluded the recovery of crucial proteins for cytokinesis, for instance the ESCRT components 44 . In order to purify intact midbodies without detergent treatment and thus reveal the complete proteome of these abscission platforms, we took advantage of the fact that released MBRs can be easily detached from the cell surface by EDTA treatment, as we previously reported 14 .
Differential centrifugations helped to enrich intact MBRs from EDTA--treated HeLa cells expressing the midbody--localized kinesin GFP--MKLP2 45 ("MidBody Enriched fraction" or "MBE", Fig. 1a ). To obtain the purest possible MBRs, we developed an original protocol for isolating fluorescent GFP--positive MBRs ("MB+") from whole cells using FACS sorting ( Fig. 1a--b and Supplementary Fig. 1a ). In parallel, we isolated small particles of the same size (1--3 µm) and granularity (SSC) but negative for GFP--MKLP2 ("MB--") ( Fig. 1a--b and Supplementary Fig. 1a ). Western blot analysis demonstrated that the MB+ population contained highly enriched known midbody proteins [MKLP1, CRIK, PRC1, PLK1, CEP55] and showed no significant contamination, as compared to MB--, total cell lysate (Tot) and MBE fractions, with intracellular compartments [Calreticulin (Endoplamic Reticulum), GM130 (Golgi), Tom22 (mitochondria), HistoneH3 (nucleus), EEA1 (endosomes)] ( Fig.  1c and Supplementary  Fig.  1b ). As expected, proteins such as ALIX, which participates both in cytokinesis and endosomal sorting in interphase were less strikingly enriched (2 fold). Remarkably, cell membrane labeling with Cell Mask and scanning electron microscopy 46 further demonstrated that MB+ fractions contained membrane--sealed, intact MBRs (Fig. 1d) , with very similar shape and length, as observed in vivo 14 . Immunofluorescence revealed that the 1--3 µm--sized objects sorted in MB+ were indeed all GFP--positive MBRs and that the respective localization of key cytokinetic proteins [MKLP2, AuroraB, MKLP1, CEP55, RacGAP1, CHMP4B, ALIX, PRC1
and CRIK] was preserved ( Fig.  1d ). Thus, this novel method to purify MBRs using FACS sorting allowed us to obtain intact and highly pure MBRs, which correspond to midbodies at the time of abscission.
We next performed proteomic and statistical analysis to 1) identify proteins detected in 7 independent MB+ preparations and 2) identify proteins significantly enriched in these preparations, as compared to MB--, MBE and/or total cell fractions. Since it is notoriously difficult to extract proteins from midbodies 47 , we used SDS to fully solubilize proteins from our different fractions after purification. For mass spectrometry analysis, two complementary methods for sample preparation were used (SDS--PAGE gel/in--gel digestion and eFASP [enhanced Filter--Aided Sample Preparation]/in--solution digestion, Supplementary Fig. 1c ). We detected a total of 1732 proteins with at least one unique identified peptide in the MB+ preparations, constituting the Total Flemmingsome Table 1 , TAB2). Interestingly, differential analyses indicated that the most abundant and most significantly enriched proteins, such as MKLP1 (KIF23), MKLP2 (KIF20A), RacGAP1, KIF4A, PRC1, KIF14, PLK1, CEP55, CRIK (CIT) corresponded to well established proteins of cytokinesis ( Fig. 1e ).
Furthermore, 150 out of the 489 proteins (31%) have been already localized to the furrow, the bridge or the midbody and/or functionally involved in cytokinesis, according to our literature search ( Supplementary Table 1 , TAB2 and dedicated website). Proteins of the Enriched Flemmingsome were highly connected and many fell into known functional categories involved in cytokinesis, such as "actin--related", "chromosomal passenger complex (CPC)--related", "microtubule--related", "traffic/transport--related" or "ESCRT--related" ( Fig. 1f and Supplementary Fig. 3 ). Thus, our approach was highly successful at identifying 150 known cytokinetic proteins and, importantly, revealed 339 new candidates potentially involved in cytokinesis/abscission. In the rest of this study, we decided to focus on a tri--partite complex ALIX (PDCD6IP)--syntenin (SDCBP)-syndecan--4 (SDC4) ( Fig. 2a ). Indeed, these three proteins were found among the most enriched in MB+ compared to all other fractions ( Fig. 1e , highlighted in red).
Colocalization of ALIX, syntenin and syndecan--4 along with ESCRT--III at the midbody and at the abscission site
In fixed cells, endogenous ALIX and CHMP4B colocalized as two parallel stripes at the midbody (hereafter figured with white brackets) in bridges without observable abscission sites, as expected ( Supplementary  Fig.  4a ). When bridges mature, the future abscission site also known as secondary ingression site (hereafter pointed with a white arrowhead) appears at the level of pinched and/or interrupted tubulin staining on one side of the midbody. At this late stage, CHMP4B staining extends from the midbody to the abscission site, often appearing as a cone shape structure on one side of the midbody, as previously reported 12, 13, 20, 21, 25, 30, 31, 39 (Fig. 2b ). We found that endogenous ALIX colocalized with CHMP4B both at the midbody and at the abscission site (to our knowledge it is the first time that ALIX is reported at the abscission site) ( Fig. 2b) .
Similarly, we observed colocalization between syndecan--4/syntenin and syntenin/ALIX, both at the midbody and at abscission site ( Fig. 2b ), using antibodies recognizing endogenous proteins (specific staining confirmed in Supplementary Fig. 4b ). Time--lapse spinning--disk confocal microscopy further revealed a striking time--dependent enrichment of these proteins, first at the midbody, then at the abscission site before the cut ( Fig. 2c and Supplementary videos 1--3). Thus syndecan--4, syntenin, ALIX and CHMP4B extensively and dynamically colocalized during the terminal steps of cytokinesis, notably at the abscission site.
Direct and hierarchical recruitment of syndecan--4, syntenin and ALIX to the cytokinetic bridge
We next investigated how syntenin and syndecan--4 are recruited to the intercellular bridge during cytokinesis. First, siRNA--mediated depletion of ALIX strongly reduced the proportion of bridges positive for endogenous syntenin ( Fig. 3a--b ). In contrast, syntenin depletion had no effect on ALIX recruitment, and syndecan--4 depletion had basically no impact on syntenin or ALIX recruitment ( Fig. 3b and Supplementary Fig. 4c ).
Importantly, upon reintroduction in ALIX--depleted cells, the ALIX F676D mutant that cannot bind to syntenin 41, 48 was unable to restore the recruitment of endogenous syntenin to the bridge, whereas wild--type ALIX could ( Fig. 3c and Supplementary   Fig. 4d ). Furthermore, a GFP--tagged syntenin ΔALIX (a triple mutant LYP--LAA that cannot interact with ALIX 41 ) was no longer recruited to the bridge, whereas GFP-syntenin wild--type and GFP--syntenin ΔSDC (harboring point mutations in PDZ1 and PDZ2 that disrupt the interaction with syndecans 41, 49 ) were ( Fig. 3d ). Thus, ALIX recruits syntenin to the intercellular bridge and this requires a direct interaction between ALIX and syntenin.
We next observed that syndecan--4 failed to be correctly recruited at bridges upon ALIX depletion (consistent with the results above) or syntenin depletion ( Fig. 3e ).
Furthermore, GFP--syndecan--4 Δsynt (a mutant deleted of the C--terminal YA motif that is essential for syntenin binding 50 ) was no longer recruited to the bridge, while the GFP-syndecan--4 ΔECD (a mutant that lacks the entire extracellular domain) was properly recruited (Fig. 3f ). These results indicate that syntenin and its interaction with syndecan--4 are necessary for syndecan--4 localization at the bridge.
Altogether, we conclude that ALIX recruits syntenin that, in turn, recruits syndecan--4 at the intercellular bridge through direct interactions.
Syndecan--4, syntenin and ALIX are required for efficient cytokinetic abscission
Functionally, time--lapse microscopy demonstrated that abscission was delayed in ALIX-depleted cells ( Fig. 4a ), as previously reported. Interestingly, abscission was also delayed after either syntenin or syndecan--4 depletions ( Fig.  4b --c). Abscission was fully restored by reintroducing either wild--type ALIX, syndecan--4 or syntenin, respectively, ruling out off--target effects (Fig.  4a --c). We conclude that ALIX, syntenin and syndecan--4 are essential for normal abscission.
Depletion of syndecan--4 or syntenin perturbs the recruitment of ESCRT--III at the abscission site but not at the midbody
We then investigated why abscission was delayed after ALIX, syntenin or syndecan--4 depletion. We first quantified the proportion of intercellular bridges with no ESCRT--III at all (early bridges), with ESCRT--III localized only at the midbody (bridges without secondary ingression) and with ESCRT--III both at the midbody and at the abscission site (bridges with constricted/interrupted tubulin staining, as in Fig. 2b ). Depletion of either ALIX, syntenin or syndecan--4 considerably reduced the number of bridges with CHMP4B at the midbody + abscission site ( Fig.  5a ). This is consistent with the observed abscission delay in depleted cells ( Fig. 4 ). Importantly, neither ALIX, syntenin nor syndecan--4 were individually required for correct ESCRT--III recruitment at the midbody itself (the proportion of bridges stuck at this earlier stage was actually increased) ( Fig. 5a ). As expected, the localization of ESCRT--III at the abscission site was restored in ALIX--, syntenin--or syndecan--4--depleted cells upon expression of siRNA--resistant versions of the corresponding wild--type proteins ( Fig. 5b--d) . Importantly, the normal localization of ESCRT--III at the abscission site could not be restored by ALIX F676D in ALIX--depleted cells ( Fig. 5b ), indicating that direct interactions between ALIX and syntenin promote the correct recruitment of ESCRT--III during cytokinesis. Of note, ALIX F676D mutant has been previously reported to rescue the increase in the number of binucleated cells observed after ALIX depletion 21, 22 . In contrast, here, we focused on ESCRT--III recruitment specifically during abscission. Using a second, complementary approach, we found that the syntenin ΔALIX mutant (that cannot bind to ALIX) could not restore normal localization of ESCRT--III during abscission ( Fig. 5c ), confirming that ALIX--syntenin interaction is indeed important for ESCRT recruitment at the abscission site. Furthermore, defects in ESCRT--III recruitment at the abscission site were also observed with the mutants syntenin ΔSDC (unable to interact with syndecan--4, Fig.  5c ) and syndecan--4 Δsynt (unable to interact with and syntenin, Fig. 5d ). In contrast, a syndecan mutant lacking the entire ectodomain (but retaining the transmembrane domain + cytoplasmic tail, syndecan--4 ΔECD) localized at the bridge and behaved as wild--type ( Fig. 5d ). Altogether, we conclude that direct interactions between ALIX and syntenin on one hand, and syntenin and syndecan on the other hand are critical for the recruitment of ESCRT--III specifically at the abscission site but not at the midbody itself.
Syndecan--4--syntenin--ALIX promotes a persistent localization of ESCRT--III at the abscission site
Finally, we investigated why ESCRT--III did not accumulate normally at the abscission site when either ALIX, syntenin or syndecan--4 were depleted, using fluorescent time-lapse microscopy in cells expressing a functional CHMP4B--GFP 31 .
In control cells, CHMP4B--GFP accumulated first at the midbody then appeared on its side as a strong, large, cone--like signal pointing toward the abscission site ( Fig.  5e and Supplementary video 4). The appearance of CHMP4B--GFP on the midbody side usually started 40 min after CHMP4B--GFP accumulation at the midbody (Fig.  5i ). The CHMP4B--GFP signal at the midbody side remained until abscission, which by mean occurred within 35 min ( Fig. 5j ). In total, the typical time between CHMP4B--GFP recruitment at the midbody and abscission was 75 min (Fig.  5k ). In cells depleted for ALIX ( Fig.  5f and Supplementary video 5) the time between the accumulation of CHMP4B at the midbody and abscission largely increased, as compared to control cells ( Fig. 5k ). Strikingly, during this period, CHMP4B--GFP signal on the midbody side took longer to appear ( Fig.  5i ). Importantly, we also noticed that the CHMP4B--GFP signal on the midbody side was less prominent and frequently disappeared as if it was unstable, something that we never observed in controls (Fig. 5f , yellow and cyan arrows highlight these transient pools of CHMP4B). As a consequence, the time between the first occurrence of CHMP4B on the midbody side and actual abscission was delayed (Fig. 5j ), and abscission eventually occurred without large, cone--shape concentration of CHMP4B at abscission site ( Fig. 5f ). In syntenin--depleted cells ( Fig. 5g and Supplementary video 6) and in syndecan--4--depleted cells ( Fig. 5h and Supplementary video 7), quantifications revealed that the times from CHMP4B--GFP recruitment at the midbody to abscission (Fig. 5k ), from CHMP4B--GFP recruitment at the midbody to appearance at the midbody side ( Fig.  5i ) and from first CHMP4B--GFP appearance at the midbody side to abscission ( Fig.   5j ) were also increased. Furthermore, we again observed an abnormal transient localization of CHMP4B--GFP on the midbody side ( Fig. 5g --h yellow and cyan arrows).
Although the phenotypes were very similar, all the measured parameters were more affected in ALIX--depleted cells as compared with syntenin--or syndecan--4--depleted cells Altogether, we conclude that syndecan--4--syntenin--ALIX promotes ESCRT--III recruitment at the abscission site and is thus key for efficient cytokinetic abscission.
DISCUSSION
Most proteins involved in cytokinetic abscission strongly accumulate at the midbody 3, 9 .
Here, we identified 489 proteins enriched in purified MBRs (Enriched Flemmingsome) ( Fig.  1 , Supplementary  Table  1 ). To isolate MBRs, we developed an original FACS--based protocol that yielded preparations that display three important features. First, the MB+ fractions were highly pure. Second, the MBRs have been obtained from unperturbed cells (no drugs for cell synchronization and no treatment for stabilizing actin or microtubules). Most importantly this purification did not involve any detergents. This allowed us to identify both transmembrane (29 proteins, Supplementary Table 1, TAB2) and membrane associated proteins in this organelle. These three points are key improvements, when comparing with previous proteomes of intercellular bridges, which already proved to be seminal in identifying new essential proteins in cytokinesis 44 Enriched Flemmingsome (489 proteins) ( Supplementary  Table  1,  TAB6) . The difference in extent of protein recovery between both studies could be explained by 1) differences in cell origins (mouse CHO vs. human HeLa), 2) differences in actual organelles (intercellular bridges before abscission vs. free midbodies as generated at the time of abscission), 3) the membrane integrity of the organelles (use of detergents vs. detergent free, thus preserving cytosolic components), 4) the reduced contaminations and the relative quantification of protein abundance (the Enriched Flemmingsome is based on significant enrichment compared to other fractions, including Total cell lysates). We were able to identify many bona fide cytosolic (ESCRT--related, actin--related, microtubule--related) and membrane/vesicle associated proteins (e.g. Rab11, Rab35, Rab8, Rab14) involved in cytokinesis 3 but undetected in previous proteomic analysis ( Fig. 1 , Supplementary Table 1 ). Intriguingly, ribosomal proteins were found enriched in the Flemmingsome, suggesting a functional interplay between cytokinesis and translation, as anticipated by studies in Drosophila 51, 52 . In addition, proteasome inhibition by MG132 has previously found to delay abscission 53 and here we revealed the presence of major proteasome components in the Enriched Flemmingsome ( Fig. 1 , Supplementary Table 1 ).
Importantly, 31% of the proteins present in the Enriched Flemmingsome (150 proteins)
were already demonstrated to be localized to the furrow, bridge or midbody during cytokinesis and/or to be involved in cytokinesis (Supplementary Table 1 , TAB2). This demonstrates the strength of our proteomic study, as well as its potential for identifying new candidates (339) important for cytokinesis. The Enriched Flemmingsome thus represents a useful resource for the cytokinesis community and we created a dedicated website (https://flemmingsome.pasteur.cloud/) with continuous updated literature on each hit, as a reference database.
Following up on the Enriched Flemmingsome, we found that ALIX, syntenin and syndecan--4 are indeed highly enriched at the midbody, then at the abscission site ( Fig. 2 ). Functional analysis demonstrated that the three proteins are required for proper abscission (Fig. 4) , and that they function together for ESCRT--III localization, specifically at the abscission site ( Fig. 3 ). Interestingly, we previously reported that syntenin can directly bridge ALIX to syndecan--1/4 in vitro, and that ALIX--syntenin-syndecan is key for budding of intraluminal vesicles in MVBs and exosome production 41 .
This likely depends on the ability of ALIX to recruit the ESCRT--III machinery at the neck of intraluminal vesicles in MVBs, but this could not be directly addressed given the small size of these necks. Here, we showed that the same module (ALIX--syntenin--syndecan--4)
is reused during cytokinesis at a much larger, micrometric scale, and found that it is actually critical for the stable association of ESCRT--III at the abscission site ( Fig. 5 ).
Our results therefore reveal that ESCRT--III recruitment during cytokinesis relies on two successive, separable phases ( Fig. 6 ). First, MKLP1--associated CEP55 directly interacts with and recruits both TSG101 and ALIX at the midbody 37 (Fig. 6a ). At the midbody, ESCRT--III components are recruited in a redundant manner, directly by ALIX and indirectly by TSG101--ESCRT--II 29 . Accordingly, both TSG101 and ALIX must be simultaneously depleted to prevent ESCRT--III recruitment at the intercellular bridge 29 .
However, ESCRT--III localization at the abscission site cannot rely on CEP55, since it is absent from this location ( Supplementary  Fig.  4e ). We now found that ALIX plays a key additional role in cytokinesis: it recruits syntenin, which in turn interacts with the transmembrane protein syndecan--4 ( Fig. 6b ). Importantly, the ALIX--syntenin--syndecan--
ONLINE METHODS
Cell cultures. HeLa cells cl--2 (ATCC) and HeLa GFP--MKLP2 45 were grown in Dulbecco's Modified Eagle Medium (DMEM) GlutaMax (31966; Gibco, Invitrogen Life Technologies) supplemented with 10% fetal bovine serum and 1X Penicillin--Streptomycin (Gibco) in 5% CO2 condition at 37°C. CHMP4B--GFP and GFP--Syndecan--4 stable cell lines were generated by electroporating HeLa ATCC cells with the corresponding plasmids, followed by G418 selection (Gibco) and selected by FACS sorting. Transfections and siRNAs. Plasmids were transfected in HeLa cells for 24 h or 48 h using X--tremeGENE 9 DNA reagent (Roche). For silencing experiments, HeLa cells were transfected once or twice with 25 nM siRNAs for 48h using HiPerFect (Qiagen) following the manufacturer's instructions. siRNAs against Luciferase (used as control, 5'CGUACGCGGAAUACUUCGA3'), ALIX (5'CCUGGAUAAUGAUGAAGGA3'), Syntenin (5'GAAGGACUCUCAAAUUGCA3') and Syndecan--4 (5'GUGAGGAUGUGUCCAACAA3') have been synthetized by Sigma. In rescue experiments, cells were first transfected for 72 h with siRNAs using HiPerFect, then cotransfected by plasmids encoding untagged proteins and either GFP or H2B--GFP to detect transfected cells, using X--tremeGENE 9 DNA reagent for an additional 24 h. SiRNA--resistant versions of ALIX, syntenin and syndecan--4 have been obtained by mutating 6 bp of the siRNA--targeting sequence using NEBaseChanger (NEB). Plasmid constructs. Human ALIX, syntenin and syndecan--4 cDNAs were subcloned into Gateway pENTR plasmids and eGFP, mScarlet or untagged transient expression vectors were generated by LR recombination (Thermo Fisher). All point mutations have been generated using NEBaseChanger (NEB), including ALIX F676D, syntenin ΔALIX (Y4A, P5A, Y46A, P47A, Y50A, P51A) 41 , syntenin ΔSDC (K119A, S171H, D172E, K173Q, K203A, K250S, D251H, S252E) 49 syndecan--4 ΔECD (deleted from E19 to E145 included), syndecan--4 Δsynt (deleted from the last two amino acids, Y197 and A198) 50 . GFP-syndecan--4 was constructed by fusing the eGFP sequence between the syndecan--4 M1--E145 and E142--A198 sequences. Western blots. Western blot experiments comparing samples used in proteomic studies. Protein extracts from Total, MBE, MB+ and MB--fractions were obtained directly after addition of 2% SDS to the samples. Proteins from approximately 2,5.10 6 MB+ from FACS were loaded after lysophilisation and resuspension in Laemmli 1x loading buffer on a 4--12% gradient SDS--Page gel (Bio--Rad). Serial dilutions (2--fold) were carried on from 5 to 10 µg extracts from Tot and MBE preparations for comparisons between the samples and SyproRuby protein blot stain (Bio--Rad) used to determine the protein concentrations in the different samples. Lanes with same levels of protein are shown in Fig. 1c and indicated as lane 1 and serial dilutions mentioned from this lane in Supplementary Fig. 1b .
Western blot experiments after siRNA treatment were carried out as follows: cells treated with siRNAs were lysed in NP--40 extract buffer (50 mM Tris, pH 8, 150 mM NaCl, 1% NP--40) containing protease inhibitors. 20µg of lysate were migrated in 10% or 4--15% gradient SDS-PAGE gels (Bio--Rad Laboratories), transferred onto PVDF membranes (Millipore) and incubated with corresponding antibodies in 5% milk in 50 mM Tris--HCl pH 8.0, 150 mM NaCl, 0.1% Tween20, followed by HRP--coupled secondary antibodies (1:20,000, Jackson ImmunoResearch) and revealed by chemiluminescence (GE Healthcare). For western blots against syndecan--4, cell extracts were treated with heparinase (AMS.HEP--ENZ III) and chondroitinase (AMS.E1028--02) for 3h at 37°C before migration. Immunofluorescence and image acquisition. HeLa cells were grown on coverslips and then fixed either with paraformaldehyde (PFA) 4% for 20 min at room temperature, with methanol for 3 min at --20°C, or with trichloroacetic acid (TCA) 10% for 20 min at room temperature. Cells were then permeabilized with 0.1% Triton--X100, blocked with PBS containing 0.2% BSA and successively incubated for 1h at room temperature with primary ( Supplementary Table 2 ) and secondary antibodies diluted in PBS containing 0.2% BSA. Cells were mounted in Mowiol (Calbiochem). DAPI staining (0.5 mg/ml, Serva). Images were acquired with an inverted TiE Nikon microscope, using a x100 1.4 NA PL--APO objective lens or a x60 1.4 NA PL--APO VC objective lens and MetaMorph software (MDS) driving a CCD camera (Photometrics Coolsnap HQ). Images were then converted into 8--bit images using ImageJ software (NIH). Purified MB+ from FACS were concentrated at 1200g and a 5µl--drop was incubated overnight on a glass coverslip. The MB+ MBRs were processed for immunofluorescence as described above for cells. Cell Mask (C10045, ThermoFisher) staining was performed on the GFP--MKLP2 adherent cells as indicated by the manufacturer, and then the MB+ MBRs purified by FACS as described above. Time--lapse microscopy. For time--lapse phase--contrast, HeLa cells were plated on glass bottom 12--well plates (MatTek) and put in an open chamber (Life Imaging) equilibrated in 5% CO2 and maintained at 37°C. Time--lapse sequences were recorded every 10 min for 48 h using a NikonEclipse TiE inverted microscope with a x20 0.45 NA Plan Fluor ELWD controlled by Metamorph software (Universal Imaging). For time--lapse fluorescent microscopy, images were acquired using an inverted Eclipse TiE Nikon microscope equipped with a CSU--X1 spinning disk confocal scanning unit (Yokogawa) and with a EMCCD Camera (Evolve 512 Delta, Photometrics). Images were acquired with a x60 1.4 NA PL--APO VC and MetaMorph software (MDS). Statistical analysis. All values are displayed as mean ± S.D. for at least three independent experiments (as indicated in the figure legends). Significance was calculated using unpaired t--tests, as indicated. For abscission times, a non--parametric Kolmogorov-Smirnov test was used. In all statistical tests p>0.05 was considered as not significant. By convention, * p<0.05; ** p<0.01 and *** p<0.001. Sample preparation for mass spectrometry. Cells were detached from flasks with 0.05% trypsin diluted in 0.02% EDTA (25300; Gibco, Invitrogen Life Technologies) and plated at 8.10 5 cells/well on 10--cm dishes for 3 days. Cells were rinsed 3--times with HBSS and then incubated in 2mM EDTA for 10 min at 37 C in order to detach MBRs from the cell surface. The "Total" fraction represented the whole fraction of detached cells including the EDTA--supernatant (SN). The cells were pelleted by centrifugation (5 min at 70 g). The "Midbody--Enriched fraction (MBE)" was adapted from ref. 14 : the supernatant from the first centrifugation was centrifuged again (5 min at 70g) and SN from this step was aliquoted to 300 µl for another centrifugation (10 min at 70g). The MBRs were concentrated from the last supernatant by 60 min centrifugation at 1200 g. FACS experimental procedures. For FACS sorting, the supernatant from the first 70g centrifugation was collected. Sorting of MBRs was performed on a BD Biosciences FACS ARIA III. Neutral Density filter 1.0 has been used to detect small particles. MBRs were gated on a pseudo--color plot looking at GFP versus SSC--A parameters, both in log scales. Cells have been excluded from the sorting gates after analysis of an unstained cell suspension as control. The MB+ (GFP--positive population) and MB--(GFP--negative population) populations purified from FACS were concentrated by 60 min centrifugation at 1200 g. The proteins from all the samples were solubilized in 2% SDS and further prepared for in--gel or in--solution digest. In gel digestion. In--gel digestion was performed by standard procedures 57 . Proteins (10 μg) were loaded on a SDS--PAGE gel (4--20% gradient, Expedeon). The electrophoretic migration of the gel was stop after the stacking and the gel was stained with Coomassie Blue (InstantBlue™, Expedeon) and each lane was cut into 3 gel bands. Gel slices were washed several times in 50 mM ammonium bicarbonate, acetonitrile (1:1) for 15 min at 37 °C. Disulfide bonds were reduced with 10mM DTT and cysteine alkylated with 55mM IAA. Trypsin (Promega) digestion was performed overnight at 37 °C in 50 mM ammonium bicarbonate. Peptides were extracted from the gel by two incubations in 10% formic acid, acetonitrile (1:1) for 15 min at 37 °C. Extracts were dried in a Speed--Vac, and resuspended in 2% acetonitrile, 0.1% formic acid prior to LC--MS/MS analysis. For each sample (Total, MBE, MB+ and corresponding MB--) 5 independent preparations were run on SDS--PAGE; an experimental replicate was made as an internal control for the MB+/MB--samples (numbered 3 and 4, Supplementary Table 1, TAB3) . In--solution digestion (eFASP). Other protein samples extracted in SDS were digested using eFASP protocol 58 . Filter units and collection tubes were incubated overnight in passivation solution: 5% (v/v) TWEEN®−20. All buffer exchanges were carried out by centrifugation at 14 000g for 10 min. Briefly, 10 µg of proteins from each sample was transferred into 30 000 MWCO centrifugal unit (Microcon® Centrifugal Filters, Merck) completed until 200 μL with exchange buffer (8 M urea, 0.2% DCA, 100 mM ammonium bicarbonate pH8.0). Disulfide bonds were reduced with 5mM TCEP (Sigma) for 1h. Proteins were buffer--exchanged with three rounds of 200 μL of exchange buffer. Buffer was then exchange for the alkylation buffer (50 mM iodoacetamide, Urea 8M, 100mM ammonium bicarbonate pH 8) in the dark for 1h. One 200 μL exchange buffer exchanges were used to remove the alkylating agent, followed by three buffer exchanges with 100 μL of digestion buffer (0,2 % DCA / 50 mM ammonium bicarbonate buffer pH 8). 100 μL of digestion buffer containing 1:50 ratio of sequencing--grade modified trypsin (Promega) to amount of protein was added to the retentate. Proteolysis was carried out at 37 °C overnight. Three rounds of 50 μL of recovery buffer (50 mM ammonium bicarbonate pH8.0) was used to elute the peptide--rich solution. Then peptides were process as described in ref. 58 and resuspended in 2% acetonitrile, 0.1% formic acid prior to LC--MS/MS analysis. For Total and MBE, 3 independent replicates were made; for MB+ and corresponding MB-- FACS--sorted samples 2 independent replicates were processed for eFASP ( Supplementary Table 1, TAB3) . Mass spectrometry analysis. Tryptic peptides from in--gel digestion were analyzed on a Q Exactive HF instrument (Thermo Fisher Scientific, Bremen) coupled with an EASY nLC 1000 chromatography system (Thermo Fisher Scientific). Sample was loaded on an in-house packed 50 cm nano--HPLC column (75 μm inner diameter) with C18 resin (1.9 μm particles, 100 Å pore size, Reprosil--Pur Basic C18--HD resin, Dr. Maisch GmbH, Ammerbuch--Entringen, Germany) after an equilibration step in 100 % solvent A (H2O, 0.1 % FA). Peptides were first eluted using a 2 to 7 % gradient of solvent B (ACN, 0.1 % FA) during 5min, then a 7 to 23 % gradient of solvent B during 80 min, a 23 to 45 % gradient of solvent B during 40 min and finally a 45 to 80 % gradient of solvent B during 5 min all at 250 nL.min --1 flow rate. The instrument method for the Q Exactive HF was set up in the data dependent acquisition mode. After a survey scan in the Orbitrap (resolution 60 000), the 10 most intense precursor ions were selected for HCD fragmentation with a normalized collision energy set up to 28. Charge state screening was enabled, and precursors with unknown charge state or a charge state of 1, 7, 8 and >8 were excluded. Dynamic exclusion was enabled for 45 s. Tryptic peptides from eFASP digestion were analyzed on a Q Exactive plus instrument (Thermo Fisher Scientific, Bremen) coupled with an EASY nLC 1000 chromatography system (Thermo Fisher Scientific). Sample was loaded on an in--house packed 50 cm nano--HPLC column (75 μm inner diameter) with C18 resin (1.9 μm particles, 100 Å pore size, Reprosil--Pur Basic C18--HD resin, Dr. Maisch GmbH, Ammerbuch--Entringen, Germany) after an equilibration step in 100 % solvent A (H2O, 0.1 % FA). Peptides were first eluted using a 2 to 5 % gradient of solvent B (ACN, 0.1 % FA) during 5min, then a 5 to 22 % gradient of solvent B during 150 min, a 22 to 45 % gradient of solvent B during 60 min and finally a 45 to 80 % gradient of solvent B during 10 min all at 250 nL.min --1 flow rate. The instrument method for the Q Exactive Plus was set up in the data dependent acquisition mode. After a survey scan in the Orbitrap (resolution 70 000), the 10 most intense precursor ions were selected for HCD fragmentation with a normalized collision energy set up to 28. Charge state screening was enabled, and precursors with unknown charge state or a charge state of 1, 7, 8 and >8 were excluded. Dynamic exclusion was enabled for 45 s. Data processing for protein identification and quantification. All data were searched using Andromeda 59 against a Human Uniprot database (downloaded in 20150818, 20204 entries), usual known mass spectrometry contaminants and reversed sequences of all entries. Andromeda searches were performed choosing trypsin as specific enzyme with a maximum number of two missed cleavages. Possible modifications included carbamidomethylation (Cys, fixed), oxidation (Met, variable) and Nter acetylation (variable). The mass tolerance in MS was set to 20 ppm for the first search then 4.5 ppm for the main search and 20 ppm for the MS/MS. Maximum peptide charge was set to seven and five amino acids were required as minimum peptide length. The "match between runs" feature was applied for samples having the same experimental condition with a maximal retention time window of 1 minute. One unique peptide to the protein group was required for the protein identification. A false discovery rate (FDR) cutoff of 1 % was applied at the peptide and protein levels. Quantification was performed using the XIC--based LFQ algorithm with the Fast LFQ mode as described in ref. 60 . Unique and razor peptides, included modified peptides, with at least 2 ratio count were used for quantification. Statistical analysis for proteomic studies. For the differential analyses, proteins identified in the reverse and contaminant databases and proteins "only identified by site" were first discarded from the list of identified proteins. Then, proteins exhibiting fewer than 2 quantified values in at least one condition were discarded from the list.
After log2 transformation of the leftover proteins, LFQ values were normalized by median centering within conditions (normalizeD function of the R package DAPAR 61 ). Remaining proteins without any LFQ value in one of both conditions have been considered as proteins quantitatively present in a condition and absent in another (Supplementary Table  1 , TAB4). They have therefore been set aside and considered as differentially abundant proteins. Next, missing values were imputed using the imp.norm function of the R package norm 62 . Proteins with a fold--change under 1.3 have been considered not significantly differentially abundant. Statistical testing of the remaining proteins (having a fold--change over 1.3) was conducted using a limma t--test 63 thanks to the R package limma 64 . An adaptive Benjamini--Hochberg procedure was applied on the resulting p--values thanks to the function adjust.p of R package cp4p 65 using the robust method described in ref. 66 to estimate the proportion of true null hypotheses among the set of statistical tests. The proteins associated to an adjusted p--value inferior to a False Discovery Rate (FDR) of 5% have been considered as significantly differentially abundant proteins. Finally, the proteins of interest are therefore those which emerge from this statistical analysis supplemented by those which are considered to be absent from one condition and present in another. Results of these differential analyses are summarized in Supplementary Fig. 2 . The merged volcano plot (Fig. 1e) is a summary of the six comparisons MB+ vs control (Neg, MBE or Total; using either eFASP or Gel). The x--axis represents the maximum log2 fold--change between MB+ and the different controls. The "merged p--value" (y--axis) has been obtained using the Fisher's method from the different p--values that have been measured in the comparisons. Note that these two quantities have been computed only when data are available.
UpsetR graph and functional association network. The Upset graph ( Supplementary  Fig.  1c ) represents the distribution of the significant proteins coming from the different statistical analyzes. The Venn diagram represents the numbers of differentially abundant proteins in function of the kind of experiment (Gel or eFASP). Functional association network was determined by STRING 67 and displayed using Cytoscape 68 . Supplementary Fig. 1a for details.
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(c) Westernblot analysis of same amounts of protein extracts from total (Tot), midbody enriched (MBE), FACS--sorted MB--and MB+ fractions. Membranes were blotted repeatedly with indicated antibodies. See Supplementary Fig. 1b for un--cropped blots and serial dilutions of the different fractions. For CRIK a long exposure is also displayed. The x--axis represent the log2 ratio between average intensities in MB+ and average intensities in controls and the y--axis is the --log10(p--value) where the p--value has been computed with a LIMMA t--test. Bar plots represent the total number of proteins that are more abundant in MB+ than in the different controls (proteins of volcano plot + proteins only quantified in a condition) and vice versa (lightblue: proteins only quantified in the control, blue: proteins significantly more abundant in the control and selected by the statistical test, lightred: proteins only quantified in MB+, red: proteins significantly more abundant in MB+ and selected by the statistical test). Supplementary Fig. 3 : Zoom on the association network displayed in Fig. 1f . Supplementary Fig. 4:  Localization  of  syntenin,  syndecan--4 and ALIX in wild--type and depleted cells.
(a) Endogenous localization of ALIX, CHMP4B, syntenin, syndecan--4 (SDC4) and acetyl-tubulin in late bridges without abscission site in fixed HeLa cells, as indicated. We used an antibody recognizing the ectodomain of SDC4 for the immunofluorescence. staining indicates that this zoomed region corresponds to a cytokinetic bridge fixed shortly before abscission. Note the colocalization between CHMP4B and syndecan--4.
Bracket and arrowhead mark the midbody and the abscission site, respectively. Scale bar = 10 µm. Table 2 : Antibodies, dilutions and fixations used in this study. Supplementary video 1: Colocalization of CHMP4B--GFP and ALIX--mScarlet at the midbody and at the abscission site.
Supplementary
HeLa cells transiently co--transfected with plasmids encoding CHMP4B--GFP and ALIX--mScarlet were recorded by spinning--disk confocal microscopy every 10 min. Merge and individual channels (in grey levels) are provided. Time 0 corresponds to the time frame preceding furrow ingression. Scale bar= 10 µm.
Supplementary video 2:
Colocalization of GFP--syntenin and ALIX--mScarlet at the midbody and at the abscission site.
HeLa cells transiently co--transfected with plasmids encoding GFP--sytenin and ALIX--mScarlet were recorded by spinning--disk confocal microscopy every 10 min. Merge and individual channels (in grey levels) are provided. Time 0 corresponds to the time frame preceding furrow ingression. Scale bar= 10 µm.
